Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06227052 · ClinicalTrials.gov registry record · Phase 4
Applying Num Vapocoolant Spray to Cervix Before Paracervical Block to Decrease Pain During Gynecology Procedures
A Phase 4 study of Pain and Pain With Paracervical Block, sponsored by Queen's Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT06227052 is a Phase 4 study of Pain and Pain With Paracervical Block that has completed, run by Queen's Medical Center. The registered enrollment target is 98 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06227052, a Phase 4 study of Pain and Pain With Paracervical Block, has completed, sponsored by Queen's Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess if Num vapocoolant spray decreases pain associated with paracervical block in gynecology procedures.
Conditions Studied
Interventions
- OTHER Placebo
- DEVICE Num Vapocoolant Spray
Study Locations (1)
Hawaii
- Queens Medical Center POB1 Clinic 1004 - Honolulu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2025-03-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06227052
The ClinicalTrials.gov registry entry for NCT06227052 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (68% lower). The listed sponsor is Queen's Medical Center, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06227052 reports 1 study location spanning 1 distinct geographic area - top geographies include Hawaii.
Frequently Asked Questions
What is clinical trial NCT06227052 about?
NCT06227052 is a clinical study titled "Applying Num Vapocoolant Spray to Cervix Before Paracervical Block to Decrease Pain During Gynecology Procedures". The purpose of this study is to assess if Num vapocoolant spray decreases pain associated with paracervical block in gynecology procedures.
What is the current status of trial NCT06227052?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2024-02-05. Estimated completion is 2025-03-07.
What conditions does trial NCT06227052 study?
This clinical trial studies the following conditions: Pain, Pain With Paracervical Block, Pain With Gynecology Procedure.
What interventions are being tested in trial NCT06227052?
The interventions under investigation include: Placebo (OTHER), Num Vapocoolant Spray (DEVICE).
Who is sponsoring clinical trial NCT06227052?
This trial is sponsored by Queen's Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06227052 being conducted?
This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.